Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Hong Kong

 

Bupa Hong Kong expands coverage to 3,600 hospitals in mainland China

Bupa Hong Kong, the Chinese division of multinational health insurer and provider Bupa, is massively expanding its coverage in mainland China, with a new scheme covering 3,600 hospitals across the country. The company is simultaneously expanding coverage to 3,000 ‘service points’ on the island of Hong Kong.

Bupa Hong Kong expands into mainland China with hospital partnerships

The Hong Kong division of multinational private health insurer and provider Bupa is expanding its direct settlement scheme into mainland China by partnering with four Chinese private hospital groups that operate in the Guangdong–Hong Kong–Macao Greater Bay Area. The move comes after Bupa Group withdrew from the country in 2023, and after the Chinese government decided to open up certain regions to foreign healthcare investment in 2024.

Apax Partners halts new investments into healthcare assets

Apax Partners, a global private equity firm based in London, has decided to stop new investments into healthcare assets as it sees fewer opportunities in the industry. The firm will now no longer have a dedicated healthcare team and will reassign the vast majority of the members to other roles, according ‘to an update to its limited partners’ seen by Bloomberg News. The firm will keep investing in ‘healthcare-adjacent businesses’.

Hillhouse and EQT vie to acquire global BPO provider GeBBS

The sale of US-based healthcare BPO firm GeBBS Healthcare Solutions has entered its final stage, with Asian and European funds competing for acquisition. Hong Kong’s Hillhouse Investment has emerged as the frontrunner and is reported to have offered approximately USD $870 million for a 100% stake, slightly ahead of Sweden’s EQT Partners' bid of $855-860 […]

Far East Drug Co. acquires majority stake in Singapore’s Fullerton Health

Fullerton Health Corporation Limited (Fullerton Health), a multinational occupational health care provider in the Asia-Pacific region, confirmed on Tuesday that pharmaceutical company Far East Drug (B.V.I.) Co. Ltd (FED) is acquiring a significant stake in the Singapore-headquartered group.

Find Us